Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyle T Helzer

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Journal of Molecular Endocrinology|May 7, 2015
Ubiquitylation of nuclear receptors: new linkages and therapeutic implicationsKyle T Helzer, Christopher Hooper, Shigeki Miyamoto, et al.
Molecular and Cellular Biology|August 29, 2022
GRHL2 Enhances Phosphorylated Estrogen Receptor (ER) Chromatin Binding and Regulates ER-Mediated Transcriptional Activation and RepressionRebecca M Reese, Kyle T Helzer, Kaelyn O Allen, et al.
Seminars in Radiation Oncology|June 18, 2023
Machine Learning & Molecular Radiation Tumor BiomarkersNicholas R Rydzewski, Kyle T Helzer, Matthew Bootsma, et al.
Journal of the Endocrine Society|March 30, 2018
17<i>β</i>-Estradiol and ICI182,780 Differentially Regulate STAT5 Isoforms in Female Mammary Epithelium, With Distinct OutcomesFatou Jallow, Jennifer L Brockman, Kyle T Helzer, et al.
Molecular and Cellular Biology|November 21, 2018
The Phosphorylated Estrogen Receptor α (ER) Cistrome Identifies a Subset of Active Enhancers Enriched for Direct ER-DNA Binding and the Transcription Factor GRHL2Kyle T Helzer, Mary Szatkowski Ozers, Mark B Meyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 19, 2022
Intrinsic Molecular Subtypes of Metastatic Castration-Resistant Prostate CancerEric Feng, Nicholas R Rydzewski, Meng Zhang, et al.
JCO Precision Oncology|March 5, 2026
Matching Patients With Cell Surface-Targeted Clinical Trials Using Large Language ModelsS Carson Callahan, Matthew R Chrostek, Nicholas Rydzewski, et al.
NPJ Genomic Medicine|October 17, 2022
Identification of phenocopies improves prediction of targeted therapy response over DNA mutations aloneHamza Bakhtiar, Kyle T Helzer, Yeonhee Park, et al.
Lab on a Chip|July 7, 2025
Lossless Altered Histone Modification Analysis System (LAHMAS)Zachary J Kauffman, Kevin Koesser, Kyle T Helzer, et al.
NPJ Precision Oncology|October 2, 2024
A phenocopy signature of TP53 loss predicts response to chemotherapyHamza Bakhtiar, Marina N Sharifi, Kyle T Helzer, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Journal of Molecular Endocrinology|May 7, 2015
Ubiquitylation of nuclear receptors: new linkages and therapeutic implicationsKyle T Helzer, Christopher Hooper, Shigeki Miyamoto, et al.
Molecular and Cellular Biology|August 29, 2022
GRHL2 Enhances Phosphorylated Estrogen Receptor (ER) Chromatin Binding and Regulates ER-Mediated Transcriptional Activation and RepressionRebecca M Reese, Kyle T Helzer, Kaelyn O Allen, et al.
Seminars in Radiation Oncology|June 18, 2023
Machine Learning & Molecular Radiation Tumor BiomarkersNicholas R Rydzewski, Kyle T Helzer, Matthew Bootsma, et al.
Journal of the Endocrine Society|March 30, 2018
17<i>β</i>-Estradiol and ICI182,780 Differentially Regulate STAT5 Isoforms in Female Mammary Epithelium, With Distinct OutcomesFatou Jallow, Jennifer L Brockman, Kyle T Helzer, et al.
Molecular and Cellular Biology|November 21, 2018
The Phosphorylated Estrogen Receptor α (ER) Cistrome Identifies a Subset of Active Enhancers Enriched for Direct ER-DNA Binding and the Transcription Factor GRHL2Kyle T Helzer, Mary Szatkowski Ozers, Mark B Meyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 19, 2022
Intrinsic Molecular Subtypes of Metastatic Castration-Resistant Prostate CancerEric Feng, Nicholas R Rydzewski, Meng Zhang, et al.
JCO Precision Oncology|March 5, 2026
Matching Patients With Cell Surface-Targeted Clinical Trials Using Large Language ModelsS Carson Callahan, Matthew R Chrostek, Nicholas Rydzewski, et al.
NPJ Genomic Medicine|October 17, 2022
Identification of phenocopies improves prediction of targeted therapy response over DNA mutations aloneHamza Bakhtiar, Kyle T Helzer, Yeonhee Park, et al.
Lab on a Chip|July 7, 2025
Lossless Altered Histone Modification Analysis System (LAHMAS)Zachary J Kauffman, Kevin Koesser, Kyle T Helzer, et al.
NPJ Precision Oncology|October 2, 2024
A phenocopy signature of TP53 loss predicts response to chemotherapyHamza Bakhtiar, Marina N Sharifi, Kyle T Helzer, et al.
Pageof 3